Actinium Pharmaceuticals (ATNM) Q2 2026 Earnings — Mixed Results

Screener

Reported August 7, 2026 · Before market open

Revenue$35.0MIn line

EPS$0.89Beat by $1.09

Revenue estimate$35.0M

EPS estimate-$0.20

Next report

Nov 13, 2026 (in 2 months)

Revenue estimate$1.2M

EPS estimate-$0.25

Versus estimates

Revenue

Q2 2026$35.0MIn line

Q3 2025$90.0KBeat by $22.5K

Diluted EPS

Q2 2026$0.89Beat by $1.09

Q1 2026-$0.18Beat by $0.04 Q4 2025-$0.19Miss by $0.00 Q3 2025-$0.16Beat by $0.09 Q2 2025-$0.22Beat by $0.10 Q1 2025-$0.51Miss by $0.25

FAQ

When did Actinium Pharmaceuticals report Q2 2026 earnings?: Actinium Pharmaceuticals (ATNM) reported Q2 2026 earnings on August 7, 2026 before market open.
What were Actinium Pharmaceuticals's Q2 2026 revenue and EPS?: Actinium Pharmaceuticals reported revenue of $35.0M and eps of $0.89 for Q2 2026.
Did Actinium Pharmaceuticals beat estimates in Q2 2026?: Revenue beat the consensus estimate of $35.0M by -. EPS beat the consensus estimate of $-0.20 by $1.09.
Where can I find Actinium Pharmaceuticals's Q2 2026 SEC filings?: You can read the 10-Q periodic report (0001213900-26-086769) directly on SEC EDGAR. The filing index links above go to sec.gov.

Ask the moment Actinium Pharmaceuticals reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Harbor at dusk